New Insights into the Treatment of Valvular Heart Disease
A special issue of Life (ISSN 2075-1729). This special issue belongs to the section "Medical Research".
Deadline for manuscript submissions: closed (31 December 2023) | Viewed by 1019
Special Issue Editors
Interests: cardiology; internal medicine; heart failure; atherosclerosis; arterial hypertension
Special Issues, Collections and Topics in MDPI journals
Interests: vulnerable plaques; atherosclerosis; heart failure; acute coronary syndromes; interventional cardiology
Special Issues, Collections and Topics in MDPI journals
Interests: cardiology; internal medicine; heart failure; atherosclerosis; arterial hypertension
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cardiovascular diseases represent the main cause of mortality worldwide, and valvular heart diseases (VHD) are among the most frequent. In recent years, the interventional treatment of VHD, mainly via transcatheter aortic valve replacement (TAVI), has begun to replace traditional open heart surgery for aortic valve corrections in many health centers, and has rapidly become the first-option therapy for several clinical conditions; meanwhile, interventional mitral valve correction using MitraClip devices has demonstrated good results in patients with heart failure and mitral insufficiency. The immediate and long-term results of an interventional procedure depend largely on the complexity and the accuracy of the image-based pre-operative assessment of the lesions. As a result of the impressive technological progress made in recent years, many new cardiac imaging methods have been developed that aim to better characterize heart diseases and provide the necessary information required for complex cardiac interventions. These include new applications of advanced 3D echocardiography and multislice cardiac computed tomography with computerized and complex 3D-based reconstructions of cardiac structures.
This Special Issue will highlight the most recent advances in the diagnostics and treatment of VHD, focusing on multimodal imaging for diagnosing VHD, modern technologies for pre-intervention assessment, and novel therapeutic techniques for the correction of diseased valves.
Prof. Dr. Ciprian Rezus
Dr. Theodora Benedek
Prof. Dr. Daniel Florin Lighezan
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- valvular heart diseases
- imaging
- TAVI
